Latest News

Methotrexate proves largely ineffective for maintaining peripheral SpA remission

Publish date: June 27, 2018

 

REPORTING FROM THE EULAR 2018 CONGRESS

SOURCE: Carron P et al. EULAR 2018 Congress, Abstract OP0335.

Pages

Recommended Reading

Physical therapy, exercise still relevant for ankylosing spondylitis
MDedge Rheumatology
Comorbid spondyloarthritis and fibromyalgia lower response to TNF inhibitors
MDedge Rheumatology
Eye-opening findings cast spondyloarthritis in new light, expert says
MDedge Rheumatology
EULAR scientific program highlights spectrum of translational research
MDedge Rheumatology
Axial SpA diagnostic strategies need not be sex-specific
MDedge Rheumatology
Ankylosing spondylitis diagnosis linked to self-harm attempts
MDedge Rheumatology
TNF inhibitor may protect against axSpA sacroiliac joint progression
MDedge Rheumatology
Observational data can’t answer question of inhibiting ankylosing spondylitis progression
MDedge Rheumatology
Biologics improve axial spondyloarthritis patients’ work performance
MDedge Rheumatology
Checkpoint inhibitors in autoimmune disease: More flares, better cancer outcomes
MDedge Rheumatology